Literature DB >> 19997128

Enhancer elements upstream of the SHOX gene are active in the developing limb.

Claudia Durand1, Fiona Bangs, Jason Signolet, Eva Decker, Cheryll Tickle, Gudrun Rappold.   

Abstract

Léri-Weill Dyschondrosteosis (LWD) is a dominant skeletal disorder characterized by short stature and distinct bone anomalies. SHOX gene mutations and deletions of regulatory elements downstream of SHOX resulting in haploinsufficiency have been found in patients with LWD. SHOX encodes a homeodomain transcription factor and is known to be expressed in the developing limb. We have now analyzed the regulatory significance of the region upstream of the SHOX gene. By comparative genomic analyses, we identified several conserved non-coding elements, which subsequently were tested in an in ovo enhancer assay in both chicken limb bud and cornea, where SHOX is also expressed. In this assay, we found three enhancers to be active in the developing chicken limb, but none were functional in the developing cornea. A screening of 60 LWD patients with an intact SHOX coding and downstream region did not yield any deletion of the upstream enhancer region. Thus, we speculate that SHOX upstream deletions occur at a lower frequency because of the structural organization of this genomic region and/or that SHOX upstream deletions may cause a phenotype that differs from the one observed in LWD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19997128      PMCID: PMC2987325          DOI: 10.1038/ejhg.2009.216

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  23 in total

1.  AT-rich palindromes mediate the constitutional t(11;22) translocation.

Authors:  L Edelmann; E Spiteri; K Koren; V Pulijaal; M G Bialer; A Shanske; R Goldberg; B E Morrow
Journal:  Am J Hum Genet       Date:  2000-11-28       Impact factor: 11.025

Review 2.  Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease.

Authors:  Christine J Shaw; James R Lupski
Journal:  Hum Mol Genet       Date:  2004-02-05       Impact factor: 6.150

3.  SHOX mutations in dyschondrosteosis (Leri-Weill syndrome).

Authors:  V Belin; V Cusin; G Viot; D Girlich; A Toutain; A Moncla; M Vekemans; M Le Merrer; A Munnich; V Cormier-Daire
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

4.  Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome.

Authors:  E Rao; B Weiss; M Fukami; A Rump; B Niesler; A Mertz; K Muroya; G Binder; S Kirsch; M Winkelmann; G Nordsiek; U Heinrich; M H Breuning; M B Ranke; A Rosenthal; T Ogata; G A Rappold
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

5.  The use of in ovo electroporation for the rapid analysis of neural-specific murine enhancers.

Authors:  J Timmer; J Johnson; L Niswander
Journal:  Genesis       Date:  2001-03       Impact factor: 2.487

6.  Phenotypic variation and genetic heterogeneity in Léri-Weill syndrome.

Authors:  S Schiller; S Spranger; B Schechinger; M Fukami; S Merker; S L Drop; J Tröger; H Knoblauch; J Kunze; J Seidel; G A Rappold
Journal:  Eur J Hum Genet       Date:  2000-01       Impact factor: 4.246

7.  Cerberus-like is a secreted factor with neutralizing activity expressed in the anterior primitive endoderm of the mouse gastrula.

Authors:  J A Belo; T Bouwmeester; L Leyns; N Kertesz; M Gallo; M Follettie; E M De Robertis
Journal:  Mech Dev       Date:  1997-11       Impact factor: 1.882

8.  Allelic and nonallelic heterogeneity in dyschondrosteosis (Leri-Weill syndrome).

Authors:  V Cormier-Daire; C Huber; A Munnich
Journal:  Am J Med Genet       Date:  2001

9.  Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain.

Authors:  J Chen; G Wildhardt; Z Zhong; R Röth; B Weiss; D Steinberger; J Decker; W F Blum; G Rappold
Journal:  J Med Genet       Date:  2009-07-02       Impact factor: 6.318

10.  New 3' elements control Pax6 expression in the developing pretectum, neural retina and olfactory region.

Authors:  Caroline Griffin; Dirk A Kleinjan; Brendan Doe; Veronica van Heyningen
Journal:  Mech Dev       Date:  2002-03       Impact factor: 1.882

View more
  20 in total

1.  Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.

Authors:  Sara Benito-Sanz; Miriam Aza-Carmona; Amaya Rodríguez-Estevez; Ixaso Rica-Etxebarria; Ricardo Gracia; Angel Campos-Barros; Karen E Heath
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

2.  Rare pseudoautosomal copy-number variations involving SHOX and/or its flanking regions in individuals with and without short stature.

Authors:  Maki Fukami; Yasuhiro Naiki; Koji Muroya; Takashi Hamajima; Shun Soneda; Reiko Horikawa; Tomoko Jinno; Momori Katsumi; Akie Nakamura; Yumi Asakura; Masanori Adachi; Tsutomu Ogata; Susumu Kanzaki
Journal:  J Hum Genet       Date:  2015-06-04       Impact factor: 3.172

Review 3.  Identification of 15 novel partial SHOX deletions and 13 partial duplications, and a review of the literature reveals intron 3 to be a hotspot region.

Authors:  Sara Benito-Sanz; Alberta Belinchon-Martínez; Miriam Aza-Carmona; Carolina de la Torre; Celine Huber; Isabel González-Casado; Judith L Ross; N Simon Thomas; Andrew R Zinn; Valerie Cormier-Daire; Karen E Heath
Journal:  J Hum Genet       Date:  2016-09-08       Impact factor: 3.172

4.  Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial.

Authors:  Imane Benabbad; Myriam Rosilio; Christopher J Child; Jean-Claude Carel; Judith L Ross; Cheri L Deal; Stenvert L S Drop; Alan G Zimmermann; Nan Jia; Charmian A Quigley; Werner F Blum
Journal:  Horm Res Paediatr       Date:  2016-12-22       Impact factor: 2.852

5.  Detection of SHOX gene aberrations in routine diagnostic practice and evaluation of phenotype scoring form effectiveness.

Authors:  Katerina Hirschfeldova; Martina Florianova; Vera Kebrdlova; Marketa Urbanova; Jitka Stekrova
Journal:  J Hum Genet       Date:  2016-10-06       Impact factor: 3.172

6.  Systematic molecular analyses of SHOX in Japanese patients with idiopathic short stature and Leri-Weill dyschondrosteosis.

Authors:  Hirohito Shima; Toshiaki Tanaka; Tsutomu Kamimaki; Sumito Dateki; Koji Muroya; Reiko Horikawa; Junko Kanno; Masanori Adachi; Yasuhiro Naiki; Hiroyuki Tanaka; Hiroyo Mabe; Hideaki Yagasaki; Shigeo Kure; Yoichi Matsubara; Toshihiro Tajima; Kenichi Kashimada; Tomohiro Ishii; Yumi Asakura; Ikuma Fujiwara; Shun Soneda; Keisuke Nagasaki; Takashi Hamajima; Susumu Kanzaki; Tomoko Jinno; Tsutomu Ogata; Maki Fukami
Journal:  J Hum Genet       Date:  2016-03-17       Impact factor: 3.172

7.  Structural and numerical changes of chromosome X in patients with esophageal atresia.

Authors:  Erwin Brosens; Elisabeth M de Jong; Tahsin Stefan Barakat; Bert H Eussen; Barbara D'haene; Elfride De Baere; Hannah Verdin; Pino J Poddighe; Robert-Jan Galjaard; Joost Gribnau; Alice S Brooks; Dick Tibboel; Annelies de Klein
Journal:  Eur J Hum Genet       Date:  2014-01-08       Impact factor: 4.246

Review 8.  cis-regulatory mutations are a genetic cause of human limb malformations.

Authors:  Julia E VanderMeer; Nadav Ahituv
Journal:  Dev Dyn       Date:  2011-01-11       Impact factor: 3.780

9.  Short Stature in Isodicentric Y Chromosome and Three Copies of the SHOX Gene: Clinical Report and Review of Literature.

Authors:  Angelo Valetto; Veronica Bertini; Angela Michelucci; Benedetta Toschi; Eleonora Dati; Giampietro I Baroncelli; Silvano Bertelloni
Journal:  Mol Syndromol       Date:  2016-03-12

Review 10.  SHOX Haploinsufficiency as a Cause of Syndromic and Nonsyndromic Short Stature.

Authors:  Maki Fukami; Atsuhito Seki; Tsutomu Ogata
Journal:  Mol Syndromol       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.